The Response Study of Yt90-Zevalin in Patients With Diffuse Large B-cell Lymphoma After 6 Cycles of CHOP

PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

September 30, 2011

Study Completion Date

May 31, 2012

Conditions
Diffuse Large B-cell Lymphoma
Interventions
DRUG

chemotherapy followed by Zevalin

6 cycles of chemotherapy with CHOP (Cyclophosphamide iv 750 mg/m2 over 15-45 minutes; Doxorubicin iv 50 mg/m2 over 5-20 minutes; and Vincristine iv 1.4 mg/m2 over 5-15 minutes on day 1 and oral prednisone 40 mg/m2 on days 1-5 repeated every 21 days), followed by Zevalin

Trial Locations (1)

10700

Siriraj Hospital, Mahidol University, Bangkoknoi

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Bayer

INDUSTRY

lead

Mahidol University

OTHER